Accès à distance ? S'identifier sur le proxy UCLouvain
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.
Primary tabs
- Open access
- 575.92 K
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès mixte |
Publication date | 2022 |
Language | Anglais |
Journal information | "Journal of geriatric oncology" - Vol. 13, no.5, p. 582-593 (2022) |
Peer reviewed | yes |
Publisher | Elsevier ((Netherlands) Amsterdam) |
issn | 1879-4068 |
e-issn | 1879-4076 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MONT - Pôle Mont Godinne UCL - (MGD) Service d'oncologie médicale |
MESH Subject | Aged ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols ; Breast Neoplasms ; Female ; Humans ; Pain ; Quality of Life ; Receptor, ErbB-2 ; Trastuzumab |
Keywords | Cyclophosphamide ; HRQoL ; Metastatic breast cancer ; Older patients ; Pertuzumab ; Trastuzumab |
Links |
Bibliographic reference | Dal Lago, Lissandra ; Uwimana, Aimé Lambert ; Coens, Corneel ; Vuylsteke, Peter ; Curigliano, Giuseppe ; et. al. Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.. In: Journal of geriatric oncology, Vol. 13, no.5, p. 582-593 (2022) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/278344 |